📰 Parent Inc News
Page 2 - Parent Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Parent Inc. Real-time updates on events, politics, business and more.
May 9, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 3, 2022
While COVID-19 pandemic has fundamentally transformed the way we work, live, and play, with many activities shifting online, it also accelerated the need for digital and tech-savvy workers, driving up the demand for quality talents in IT and tech on the end of employers. This digital shift has re
March 1, 2022
More than 80,000 job opportunities, including 2,000 tech jobs, are being offered by over 200 local companies, according to online job portal JobStreet. JobStreet x Tech In Asia JobStreet has partnered with technology news website Tech in Asia (TIA) to bring in the biggest career fair in the reg
January 18, 2022
Alongside Staples continued pursuit of the Consumer unit, ODP said it has received a proposal from another third party that it is considering.
January 14, 2022
Item 8.01. Other Events. In May 2021, The ODP Corporation announced that its Board of Directors unanimously approved a plan to separate the Company into two independent, publicly-traded companies by... | January 14, 2022
January 14, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 14, 2022
WASHINGTON (dpa-AFX) - The ODP Corp. (ODP) announced Thursday that its Board of Directors determined to delay the previously announced public company separation to evaluate a potential sale of
November 5, 2021
/PRNewswire/ -- USR Parent, Inc. ("Staples") today reaffirmed its June 4, 2021 proposal to The ODP Corporation (together with its subsidiaries, the "Company")...
November 5, 2021
/PRNewswire/ -- USR Parent, Inc. ("Staples") today reaffirmed its June 4, 2021 proposal to The ODP Corporation (together with its subsidiaries, the "Company")...
October 29, 2021
The Food and Drug Administration on Friday authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in children ages 5 to 11, a major step in making the shots available to school-aged kids by early November.